search
Back to results

Uganda Housing Modification Study (UHMS)

Primary Purpose

Malaria, Anemia

Status
Active
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
Eave Tubes
Eave Ribbons
Full House Screening
Partial House Screening
Sponsored by
Infectious Diseases Research Collaboration, Uganda
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Malaria focused on measuring Housing Modification, Vector Control, Uganda, Malaria Control

Eligibility Criteria

undefined - 14 Years (Child)All SexesAccepts Healthy Volunteers

Phase I

Inclusion criteria

  • At least one adult aged 18 years or older present
  • Agreement of the adult resident to provide informed consent for the pilot study

Phase II

Cohort Study

Inclusion Criteria:

  • Household considered their primary residence
  • Child aged less than 59 months
  • Agreement to come to the study clinic for any febrile illness
  • Agreement to avoid antimalarial medications outside the study
  • Provision of written informed consent (for parent or guardian in case of children)

Cross-sectional Community Survey - Household Survey

Inclusion Criteria:

  • At least one household resident between 6 months and 14 years of age present (with an adult caregiver willing to provide informed consent for the clinical survey)
  • At least one adult aged 18 years or older present
  • Adult is a usual resident who slept in the sampled household on the night before the survey
  • Agreement of the adult resident to provide informed consent for the household survey

Exclusion Criteria:

  • Dwelling destroyed or not found
  • Household vacant
  • No adult resident home on more than 3 occasions

Cross-sectional Community Survey - Clinical Survey

Inclusion Criteria:

  • Child aged 6 months to 14 years
  • Usual resident who was present in the sampled household on the night before the survey
  • Agreement of parent/guardian to provide informed consent
  • Agreement of child aged 8 years or older to provide assent

Exclusion Criterion:

  • Child not home on day of survey

Recruitment of Field Workers for entomology activities (human landing catches).

Inclusion Criteria:

  • Willingness to take chemoprophylaxis for malaria
  • Willingness to abstain from alcohol during working hours
  • No significant past medical history.

Sites / Locations

  • Infectious Diseases Research Collaboration

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm 10

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

No Intervention

No Intervention

Arm Label

Eave Tubes - Traditional House

Eave Tubes - Modern House

Eave Ribbons - Traditional House

Eave Ribbons - Modern House

Full House Screening - Traditional House

Full House Screening - Modern House

Partial House Screening - Traditional House

Partial House Screening - Modern House

Control - Traditional House

Control - Modern House

Arm Description

Installation of eave tubes in traditional homes.

Installation of eave tubes in modern homes.

Installation of eave ribbons in traditional homes.

Installation of eave ribbons in modern homes.

Installation of full house screening, includes screening eaves and windows, in traditional homes.

Installation of full house screening, includes screening eaves and windows, in modern homes.

Installation of partial screening, includee either screening of the eaves or installing a screened ceiling, in traditional homes.

Installation of partial screening, includee either screening of the eaves or installing a screened ceiling, in modern homes.

Control group with no intervention in traditional homes

Control group with no intervention in modern homes.

Outcomes

Primary Outcome Measures

Incidence of malaria
Number of incident episodes of clinical malaria per time of observation. Incident episodes of malaria defined as any treatment for malaria > 14 days after any prior treatment for malaria

Secondary Outcome Measures

Parasite prevalence
Proportion of study participants with a thick blood smear positive for asexual parasites as measured by microscopy
Prevalence of anaemia
Proportion of haemoglobin measurements categorised as anaemia as per WHO age-stratified guidelines
Vector density
Number of female Anopheles mosquitoes captured/room per night by CDC light traps
Sporozoite rate
Proportion of captured female Anopheles mosquitoes that test positive for sporozoites
Annual entomological inoculation rate
Number of infected bites per person per year (human biting rate x sporozoite rate x 365 days/year)
Proportion of mosquitoes with insecticide resistance
Proportion of mosquitoes with phenotypic expression of insecticide resistance or containing genetic polymorphisms associated with resistance to insecticides of interest as identified by PCR
Proportion of individuals satisfied with the interventions
Indicator of acceptability
Proportion of households that require minimal maintenance of the implemented intervention over the period of the study, by study intervention
Indicator of durability
Longer term cost of the maintenance and upkeep of the implemented intervention, by study intervention
Indicator of durability
Costs of housing improvements, including maintenance, by improvement type
Indicator of feasibility
Incremental cost-effectiveness ratios (ICER) of each package
Cost per malaria case averted, Cost per DALY averted
Proportion of households that received the assigned housing modification
Indicator of fidelity
Proportion of households that received 1 PBO LLIN for every 2 residents
Indicator of fidelity
Proportion of households that received full/partial/no housing modifications
Dose delivered
Proportion of households that received adequate/inadequate/no PBO LLINs
Dose delivered
Proportion of households that utilized full/partial/no housing modifications
Dose received
Proportion of household residents that slept under a PBO LLIN the previous night
Dose received
Proportion of households that were fully covered by the assigned housing modification
Indicator of reach
Proportion of household residents that were fully covered by the PBO LLINs
Indicator of reach Proportion of households fully covered by both the modifications & PBO LLINs
Proportion of households fully covered by both the modifications & PBO LLINs
Indicator of reach

Full Information

First Posted
November 4, 2020
Last Updated
August 2, 2022
Sponsor
Infectious Diseases Research Collaboration, Uganda
Collaborators
Centers for Disease Control and Prevention, United States Agency for International Development (USAID), London School of Hygiene and Tropical Medicine, University of California, San Francisco
search

1. Study Identification

Unique Protocol Identification Number
NCT04622241
Brief Title
Uganda Housing Modification Study
Acronym
UHMS
Official Title
Impact of Housing Modifications Combined With Piperonyl Butoxide (PBO) Long-lasting Insecticidal Nets (LLINs) on the Malaria Burden in Uganda: a Cluster-randomised Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 29, 2021 (Actual)
Primary Completion Date
May 2023 (Anticipated)
Study Completion Date
July 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Infectious Diseases Research Collaboration, Uganda
Collaborators
Centers for Disease Control and Prevention, United States Agency for International Development (USAID), London School of Hygiene and Tropical Medicine, University of California, San Francisco

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To explore housing modification as a malaria control intervention, and to assess the degree to which it may offer protection in moderate to high malaria endemicity settings, we propose a two-phase study evaluating epidemiological and entomological effectiveness, cost-effectiveness, feasibility, and acceptability of housing modification in Uganda. The first phase will be a pilot implementation assessing the feasibility of candidate housing modification interventions, followed by a cluster randomised control trial of the most effective, scalable, and cost-effective interventions.
Detailed Description
The study will be conducted in two phases, beginning with a pilot (Phase I). The aim of the pilot will be to develop and test four types of housing modifications in both modern houses (those with brick or stone walls) and traditionally constructed houses (those with mud walls). The housing modifications will include: (1) full house screening (eaves and windows), (2) partial house screening (eaves or ceiling), (3) eave tubes, and (4) eave ribbons. Community input will be sought during the development of the housing prototypes. In the pilot, all 4 interventions will be implemented in both modern and traditional houses, plus a control arm in each group. All households will have access to PBO LLINs. Community input will be sought during the development of the housing prototypes. The pilot will include 10 arms in total, each consisting of 20 households, equal to 200 households (160 in the intervention and 40 in the control arm) in total. The feasibility and effectiveness of the interventions will be assessed through a qualitative study (FGDs and interviews), evaluation of the costs and implementation of the interventions, and entomology surveys (using CDC light traps). One to two housing interventions will be selected for Phase II following the review and discussion of the pilot results with the trial steering committee. Phase II will include a cluster-randomised trial. A cluster will be defined as a village (or segment of a village consisting of ~100 households). In the cluster-randomised trial, up to 2 interventions vs 1 control arm will be assessed in 20 clusters per arm (60 clusters total). The clusters will be non-contiguous, with a buffer zone of 300-500m. All households in the selected clusters will have PBO LLINs; households in intervention clusters will also receive the specified housing modifications. The impact of the interventions will be assessed through a cohort study, cross-sectional community surveys, entomology surveillance, a qualitative study, and an economic evaluation. The primary outcome of the trial will be clinical malaria incidence in children aged < 60 months as measured in the cohort study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria, Anemia
Keywords
Housing Modification, Vector Control, Uganda, Malaria Control

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Phase II will be carried out as a cluster-randomized trial with 3 arms (2 interventions selected from the pilot study, and 1 control). There will be 20 clusters per arm (60 clusters total) and a cluster will be defined as an enumeration area within a village. All participating households in the selected clusters will have PBO LLINs, and households in intervention clusters will also receive the specified housing modifications. The impact of the interventions on malaria burden will be assessed through a cohort study, cross-sectional community surveys, entomology surveillance, a qualitative study, and an economic evaluation. The primary outcome of the trial will be clinical malaria incidence in children aged < 60 months.
Masking
None (Open Label)
Masking Description
Masking is not possible due to the nature of the intervention.
Allocation
Randomized
Enrollment
2422 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Eave Tubes - Traditional House
Arm Type
Experimental
Arm Description
Installation of eave tubes in traditional homes.
Arm Title
Eave Tubes - Modern House
Arm Type
Experimental
Arm Description
Installation of eave tubes in modern homes.
Arm Title
Eave Ribbons - Traditional House
Arm Type
Experimental
Arm Description
Installation of eave ribbons in traditional homes.
Arm Title
Eave Ribbons - Modern House
Arm Type
Experimental
Arm Description
Installation of eave ribbons in modern homes.
Arm Title
Full House Screening - Traditional House
Arm Type
Experimental
Arm Description
Installation of full house screening, includes screening eaves and windows, in traditional homes.
Arm Title
Full House Screening - Modern House
Arm Type
Experimental
Arm Description
Installation of full house screening, includes screening eaves and windows, in modern homes.
Arm Title
Partial House Screening - Traditional House
Arm Type
Experimental
Arm Description
Installation of partial screening, includee either screening of the eaves or installing a screened ceiling, in traditional homes.
Arm Title
Partial House Screening - Modern House
Arm Type
Experimental
Arm Description
Installation of partial screening, includee either screening of the eaves or installing a screened ceiling, in modern homes.
Arm Title
Control - Traditional House
Arm Type
No Intervention
Arm Description
Control group with no intervention in traditional homes
Arm Title
Control - Modern House
Arm Type
No Intervention
Arm Description
Control group with no intervention in modern homes.
Intervention Type
Other
Intervention Name(s)
Eave Tubes
Intervention Description
The eave tubes are PVC tubes with a diameter of 15 cm installed in the outer wall of occupied rooms (e.g. bedrooms and living rooms but not storage rooms) at 1.5-2 m intervals, fitted with electrostatic mesh inserts coated with insecticides. No additional screening will be done. All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Intervention Type
Other
Intervention Name(s)
Eave Ribbons
Intervention Description
Eave ribbons are 15 cm-wide triple-layered hessian fabrics (burlap-line fabric woven from sisal fibres, procured locally), in lengths starting 1 m that can be attached to houses using nails, adhesives or Velcro, without completely closing eave-spaces. The eave ribbons will be treated by study staff with a commonly used spatial repellent, transfluthrin. Eave ribbons will be retreated by study staff after 6 months (only in Phase II, if selected for inclusion in the cluster-randomised trial). All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Intervention Type
Other
Intervention Name(s)
Full House Screening
Intervention Description
Full house screening includes screening eaves/ceilings, ventilation openings, and windows. Eaves/ceiling, air vents, and windows of eligible houses will be screened with wire mesh or other locally available screening materials. or ceilings, if eaves are closed" and ventilation openings. We are also filling in any gaps in the walls. All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Intervention Type
Other
Intervention Name(s)
Partial House Screening
Intervention Description
Partial screening will include either screening of the eaves or installing a screened ceiling, where no ceiling is present. In traditional houses, a netting (either insecticide-impregnated or untreated) may be either fixed in multiple places in the rafters or by hanging from a single central point and attached to the walls. No other screening or filling of the gaps will be done in partially screened houses.All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Primary Outcome Measure Information:
Title
Incidence of malaria
Description
Number of incident episodes of clinical malaria per time of observation. Incident episodes of malaria defined as any treatment for malaria > 14 days after any prior treatment for malaria
Time Frame
12 months following housing modification
Secondary Outcome Measure Information:
Title
Parasite prevalence
Description
Proportion of study participants with a thick blood smear positive for asexual parasites as measured by microscopy
Time Frame
12 months following housing modification
Title
Prevalence of anaemia
Description
Proportion of haemoglobin measurements categorised as anaemia as per WHO age-stratified guidelines
Time Frame
12 months following housing modification
Title
Vector density
Description
Number of female Anopheles mosquitoes captured/room per night by CDC light traps
Time Frame
12 months following housing modification
Title
Sporozoite rate
Description
Proportion of captured female Anopheles mosquitoes that test positive for sporozoites
Time Frame
12 months following housing modification
Title
Annual entomological inoculation rate
Description
Number of infected bites per person per year (human biting rate x sporozoite rate x 365 days/year)
Time Frame
12 months following housing modification
Title
Proportion of mosquitoes with insecticide resistance
Description
Proportion of mosquitoes with phenotypic expression of insecticide resistance or containing genetic polymorphisms associated with resistance to insecticides of interest as identified by PCR
Time Frame
12 months following housing modification
Title
Proportion of individuals satisfied with the interventions
Description
Indicator of acceptability
Time Frame
12 months following housing modification
Title
Proportion of households that require minimal maintenance of the implemented intervention over the period of the study, by study intervention
Description
Indicator of durability
Time Frame
12 months following housing modification
Title
Longer term cost of the maintenance and upkeep of the implemented intervention, by study intervention
Description
Indicator of durability
Time Frame
12 months following housing modification
Title
Costs of housing improvements, including maintenance, by improvement type
Description
Indicator of feasibility
Time Frame
12 months following housing modification
Title
Incremental cost-effectiveness ratios (ICER) of each package
Description
Cost per malaria case averted, Cost per DALY averted
Time Frame
12 months following housing modification
Title
Proportion of households that received the assigned housing modification
Description
Indicator of fidelity
Time Frame
12 months following housing modification
Title
Proportion of households that received 1 PBO LLIN for every 2 residents
Description
Indicator of fidelity
Time Frame
12 months following housing modification
Title
Proportion of households that received full/partial/no housing modifications
Description
Dose delivered
Time Frame
12 months following housing modification
Title
Proportion of households that received adequate/inadequate/no PBO LLINs
Description
Dose delivered
Time Frame
12 months following housing modification
Title
Proportion of households that utilized full/partial/no housing modifications
Description
Dose received
Time Frame
12 months following housing modification
Title
Proportion of household residents that slept under a PBO LLIN the previous night
Description
Dose received
Time Frame
12 months following housing modification
Title
Proportion of households that were fully covered by the assigned housing modification
Description
Indicator of reach
Time Frame
12 months following housing modification
Title
Proportion of household residents that were fully covered by the PBO LLINs
Description
Indicator of reach Proportion of households fully covered by both the modifications & PBO LLINs
Time Frame
12 months following housing modification
Title
Proportion of households fully covered by both the modifications & PBO LLINs
Description
Indicator of reach
Time Frame
12 months following housing modification

10. Eligibility

Sex
All
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Phase I Inclusion criteria At least one adult aged 18 years or older present Agreement of the adult resident to provide informed consent for the pilot study Phase II Cohort Study Inclusion Criteria: Household considered their primary residence Child aged less than 59 months Agreement to come to the study clinic for any febrile illness Agreement to avoid antimalarial medications outside the study Provision of written informed consent (for parent or guardian in case of children) Cross-sectional Community Survey - Household Survey Inclusion Criteria: At least one household resident between 6 months and 14 years of age present (with an adult caregiver willing to provide informed consent for the clinical survey) At least one adult aged 18 years or older present Adult is a usual resident who slept in the sampled household on the night before the survey Agreement of the adult resident to provide informed consent for the household survey Exclusion Criteria: Dwelling destroyed or not found Household vacant No adult resident home on more than 3 occasions Cross-sectional Community Survey - Clinical Survey Inclusion Criteria: Child aged 6 months to 14 years Usual resident who was present in the sampled household on the night before the survey Agreement of parent/guardian to provide informed consent Agreement of child aged 8 years or older to provide assent Exclusion Criterion: Child not home on day of survey Recruitment of Field Workers for entomology activities (human landing catches). Inclusion Criteria: Willingness to take chemoprophylaxis for malaria Willingness to abstain from alcohol during working hours No significant past medical history.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nelli Westercamp, PhD MBA
Organizational Affiliation
Centers for Disease Control and Prevention
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Moses Kamya, MBChB PhD
Organizational Affiliation
Infectious Diseases Research Collaboration
Official's Role
Principal Investigator
Facility Information:
Facility Name
Infectious Diseases Research Collaboration
City
Kampala
State/Province
Central Region
Country
Uganda

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Uganda Housing Modification Study

We'll reach out to this number within 24 hrs